Client Result

Commercial Due Diligence in Digital Pathology

Project Overview

An early-stage venture firm requested a high-level commercial due diligence of a potential investment in the digital pathology space

DeciBio Approach

Primary Research

  • Conducted 13 interviews with experts from biopharma, clinical settings, and industry to assess the company's value proposition

Secondary Research

  • Assessed the competitive landscape and clinical workflows in specific indications to understand how the company's technology would integrate into the existing clinical paradigm
At a glance
Key Competitors Profiled

DeciBio presented a deliverable detailing the digital pathology landscape, the company's ability to compete in the space, and potential go-to-market plans and considerations.

Quantitative Analysis

  • Company revenue estimation using comparable competitors as benchmarks

Qualitative Analysis

  • Potential clinical pricing / commercialization models
  • Timeline to clinic
  • Clinical go-to-market considerations by geography and stakeholder type

4 weeks

Geographic Scope

U.S. and Europe


Pharma & Biotech


Due Diligence

Revenue Projection

Competitive Analysis

Go-to-Market Strategy

Pricing Strategy

Novel Technology Commercialization

Related Client Results

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.